These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 830773)

  • 41. Identification and characterization of plasma kallikrein-kinin system inhibitors from salivary glands of the blood-sucking insect Triatoma infestans.
    Isawa H; Orito Y; Jingushi N; Iwanaga S; Morita A; Chinzei Y; Yuda M
    FEBS J; 2007 Aug; 274(16):4271-86. PubMed ID: 17645545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding and dissociation of Hageman factor, prekallikrein and high molecular weight kininogen in human plasma during contact activation.
    Nakahara M
    Biochem Pharmacol; 1980 May; 29(9):1247-54. PubMed ID: 6772195
    [No Abstract]   [Full Text] [Related]  

  • 43. Patho-physiology of kallikrein system.
    Colman RW
    Ann Clin Lab Sci; 1980; 10(3):220-6. PubMed ID: 6901589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein.
    Wiggins RC
    J Biol Chem; 1983 Jul; 258(14):8963-70. PubMed ID: 6553057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of factor XI and high molecular weight kininogen in human plasma.
    Thompson RE; Mandle R; Kaplan AP
    J Clin Invest; 1977 Dec; 60(6):1376-80. PubMed ID: 915004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prekallikrein activation in the adult respiratory distress syndrome.
    Schapira M; Gardaz JP; Py P; Lew PD; Perrin LH; Suter PM
    Bull Eur Physiopathol Respir; 1985; 21(3):237-41. PubMed ID: 3873975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies on prekallikrein of bovine plasma. II. Activation of prekallikrein with proteinases and properties of kallikrein activated by bovine Hageman factor.
    Takahashi H; Nagasawa S; Suzuki T
    J Biochem; 1980 Jan; 87(1):23-34. PubMed ID: 6766924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Zinc-dependent activation of the plasma kinin-forming cascade by aggregated beta amyloid protein.
    Shibayama Y; Joseph K; Nakazawa Y; Ghebreihiwet B; Peerschke EI; Kaplan AP
    Clin Immunol; 1999 Jan; 90(1):89-99. PubMed ID: 9884356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The kallikrein-kinin system in operated and non-operated patients with acute pancreatitis.
    Hiltunen J; Kaukinen S; Pessi T; Ylitalo P
    Acta Chir Scand; 1985; 151(4):371-5. PubMed ID: 3849928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of a microassay for human plasma prekallikrein.
    De La Cadena RA; Scott CF; Colman RW
    J Lab Clin Med; 1987 May; 109(5):601-7. PubMed ID: 3646287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.
    Colman RW; Mattler L; Sherry S
    J Clin Invest; 1969 Jan; 48(1):23-32. PubMed ID: 4237065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of human Hageman factor by a leukocytic protease.
    Newball HH; Revak SD; Cochrane CG; Griffin JH; Lichtenstein LM
    Adv Exp Med Biol; 1979; 120B():139-51. PubMed ID: 517231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms for Hageman factor activation and role of HMW kininogen as a coagulation cofactor.
    Kaplan AP; Silverberg M; Dunn JT; Miller G
    Ann N Y Acad Sci; 1981; 370():253-60. PubMed ID: 6455951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assay of prekallikrein in human plasma: comparison of amidolytic, esterolytic, coagulation, and immunochemical assays.
    Fisher CA; Schmaier AH; Addonizio VP; Colman RW
    Blood; 1982 May; 59(5):963-70. PubMed ID: 6803857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hyperprolactinemia and reduction in plasma titers of Hageman factor, prekallikrein, and high molecular weight kininogen in patients with acute myocardial infarction.
    La Follette L; Gordon EM; Mazur CA; Ratnoff OD; Yamashita TS
    J Lab Clin Med; 1987 Sep; 110(3):318-21. PubMed ID: 3649393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hepatic protein synthesis of the kallikrein-kininogen-kinin system].
    Adam A; Reynaert M; Damas P; Ers P; Boulanger J; Roeseler J; Faymonville ME; Lamy M; Damas J
    Presse Med; 1988 Feb; 17(4):151-4. PubMed ID: 2964610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surface activation of factor XII (Hageman factor)--critical role of high molecular weight kininogen and another potentiator).
    Chan JY; Burrowes CE; Movat HZ
    Agents Actions; 1978 Jan; 8(1-2):65-72. PubMed ID: 636957
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of t-AMCHA and EACA on the plasma kallikrein system.
    Nakahara M
    Thromb Haemost; 1977 Feb; 37(1):104-10. PubMed ID: 576509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The contact activation mechanism in human plasma: activation induced by dextran sulfate.
    van der Graaf F; Keus FJ; Vlooswijk RA; Bouma BN
    Blood; 1982 Jun; 59(6):1225-33. PubMed ID: 6177360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Role of the blood kinin system in the pathogenesis of the hemorrhagic syndrome in hemorrhagic vasculitis].
    Bleian GT; Pogosian AS; Stepanian MA; Osipova EN
    Vopr Med Khim; 1978; 24(6):779-81. PubMed ID: 734977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.